IBDEI2M3 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43837,0)
 ;;=L60.4^^200^2217^88
 ;;^UTILITY(U,$J,358.3,43837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43837,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,43837,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,43837,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,43838,0)
 ;;=L60.5^^200^2217^290
 ;;^UTILITY(U,$J,358.3,43838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43838,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,43838,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,43838,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,43839,0)
 ;;=L60.8^^200^2217^168
 ;;^UTILITY(U,$J,358.3,43839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43839,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,43839,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,43839,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,43840,0)
 ;;=L62.^^200^2217^169
 ;;^UTILITY(U,$J,358.3,43840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43840,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,43840,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,43840,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,43841,0)
 ;;=L64.9^^200^2217^33
 ;;^UTILITY(U,$J,358.3,43841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43841,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,43841,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,43841,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,43842,0)
 ;;=L65.9^^200^2217^231
 ;;^UTILITY(U,$J,358.3,43842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43842,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,43842,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,43842,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,43843,0)
 ;;=L70.0^^200^2217^6
 ;;^UTILITY(U,$J,358.3,43843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43843,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,43843,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,43843,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,43844,0)
 ;;=L70.1^^200^2217^1
 ;;^UTILITY(U,$J,358.3,43844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43844,1,3,0)
 ;;=3^Acne Conglobata
 ;;^UTILITY(U,$J,358.3,43844,1,4,0)
 ;;=4^L70.1
 ;;^UTILITY(U,$J,358.3,43844,2)
 ;;=^5009269
 ;;^UTILITY(U,$J,358.3,43845,0)
 ;;=L70.3^^200^2217^5
 ;;^UTILITY(U,$J,358.3,43845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43845,1,3,0)
 ;;=3^Acne Tropica
 ;;^UTILITY(U,$J,358.3,43845,1,4,0)
 ;;=4^L70.3
 ;;^UTILITY(U,$J,358.3,43845,2)
 ;;=^5009270
 ;;^UTILITY(U,$J,358.3,43846,0)
 ;;=L70.5^^200^2217^2
 ;;^UTILITY(U,$J,358.3,43846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43846,1,3,0)
 ;;=3^Acne Excoriee des Jeunes Filles
 ;;^UTILITY(U,$J,358.3,43846,1,4,0)
 ;;=4^L70.5
 ;;^UTILITY(U,$J,358.3,43846,2)
 ;;=^5009272
 ;;^UTILITY(U,$J,358.3,43847,0)
 ;;=L70.8^^200^2217^4
 ;;^UTILITY(U,$J,358.3,43847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43847,1,3,0)
 ;;=3^Acne NEC
 ;;^UTILITY(U,$J,358.3,43847,1,4,0)
 ;;=4^L70.8
 ;;^UTILITY(U,$J,358.3,43847,2)
 ;;=^87239
 ;;^UTILITY(U,$J,358.3,43848,0)
 ;;=L70.9^^200^2217^7
 ;;^UTILITY(U,$J,358.3,43848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43848,1,3,0)
 ;;=3^Acne,Unspec
 ;;^UTILITY(U,$J,358.3,43848,1,4,0)
 ;;=4^L70.9
 ;;^UTILITY(U,$J,358.3,43848,2)
 ;;=^5009273
 ;;^UTILITY(U,$J,358.3,43849,0)
 ;;=L71.0^^200^2217^235
 ;;^UTILITY(U,$J,358.3,43849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43849,1,3,0)
 ;;=3^Perioral Dermatitis
 ;;^UTILITY(U,$J,358.3,43849,1,4,0)
 ;;=4^L71.0
 ;;^UTILITY(U,$J,358.3,43849,2)
 ;;=^5009274
 ;;^UTILITY(U,$J,358.3,43850,0)
 ;;=L71.1^^200^2217^259
 ;;^UTILITY(U,$J,358.3,43850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43850,1,3,0)
 ;;=3^Rhinophyma
